The following is a summary of “Comparative Outcomes of Left Main and Non-Left Main Percutaneous Coronary Intervention from ...

57 A recent analysis of the Valsartan in Acute Myocardial Infarction Trial (VALIANT) assessed the incidence and timing of ... Along the broad spectrum of severity of ischemic HF, specific clinical ...

Since 1999, both stent use and left internal mammary-artery grafting have become more common. The most recent randomized trial data show that rates of death, MI, and stroke remain similar for CABG ...

Bisoprolol is clinically feasible option in reducing resting heart rate (RHR) and improving left ventricular ejection ...

Stents and coronary artery bypass grafting (CABG ... Stenting is a quick way to open a blocked artery. In an emergency, it is usually preferred over CABG. An acute ST-segment elevation myocardial ...

A high degree of heart rate (HR) variability is found in compensated hearts with good function, whereas HR variability can be decreased with severe coronary artery disease, congestive heart failure, ...

Updates in new antiplatelet therapies, new patient populations for PCI and AI to guide CAD staging were among the top ...

Around 40% of all patients undergoing angiography are found to have normal coronary arteries or non-obstructive coronary artery disease (NOCAD). Despite the high prevalence, this is a group who rarely ...

Both incident and recurrent heart failure hospitalization risk is associated with post-traumatic stress disorder among patients with CAD.

The concept of using the vein system as a way to guarantee myocardial perfusion in the presence of coronary artery disease is attractive for three principal reasons: (1) the coronary vein system has a ...